Q3 2025 Tarsons Products Ltd Earnings Call Transcript
Key Points
- Tarsons Products Ltd (BOM:543399) reported a 23.3% year-over-year increase in standalone revenues for Q3 FY25, reaching INR76.2 crores, marking the highest ever revenue recorded in a third quarter for the company.
- The company achieved a 50.4% year-on-year growth in exports, reflecting positive momentum and industry revival.
- The Panchla facility is progressing as planned, with commercial production for certain products already commenced, and full ramp-up anticipated in the first half of the next fiscal year.
- Tarsons Products Ltd (BOM:543399) is actively enhancing its international presence by participating in trade fairs and strengthening its distribution network, aiming to boost overseas revenue.
- The company is well-positioned to capitalize on the growing demand in the labware industry, driven by increasing research activities in life sciences, biotechnology, and healthcare sectors.
- The standalone EBITDA margin for Q3 FY25 decreased by 30 basis points to 36.7%, primarily due to higher fixed costs associated with the new Panchla facility.
- Consolidated profit after tax for Q3 FY25 was INR5.3 crores, with a PAT margin of 5.5%, impacted by higher depreciation charges from the Panchla plant.
- Nerbe's revenue remained flat over the last four quarters, attributed to challenging market conditions in Europe.
- The company's PAT margin is currently affected by high interest and depreciation components, with expectations of improvement only by FY27.
- The full revenue potential from the expanded capacity at the Panchla plant is expected to take three to four years to materialize, indicating a slow ramp-up.
Ladies and gentlemen, good day, and welcome to Tarsons Products Limited Q3 FY25 earnings call hosted by Ambit Capital Limited. (Operator Instructions)
Please note that this conference call is being recorded. This conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions and expectations of the company as on date of this call. These statements do not guarantee the future performance of the company, and it may involve risks and uncertainties that are difficult to predict.
I now hand the conference over to Mr. Samarth Agarwal from Ambit Capital.
Good afternoon, everyone. On behalf of Ambit Capital, I welcome you all to Tarsons Products 3Q FY25 Earnings Conference Call. From the management today, we have Mr. Aryan Sehgal, Promotor and Whole-time Director; and Mr. Santosh Agarwal, the CFO.
Now without further ado, I would now request Aryan to start with his opening remarks, post which we can open the floor for Q&A.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
